{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"data_sharing_plan":["IPD Sharing (as of May 2023): No"],"condition":["Peritoneal Neoplasms","Carcinoma","Colorectal Cancer"],"disease":["Peritoneal Neoplasms","Carcinoma","Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2252055"],"location":["France"],"study_start_month":["5"],"keyword":["Oxaliplatin","Oxycodone"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC","description":"This study determine the maximal tolerate dose","dates":{"creation":"2016-05-15"},"accession":"2252055","cross_references":{"ClinicalTrials___gov":["NCT03253133"]}}